z-logo
open-access-imgOpen Access
Biologics' switching: new insights toward establishing practice norms
Author(s) -
Mahagna Hussein,
Ben-Horin Shomron
Publication year - 2019
Publication title -
ueg journal
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.667
H-Index - 35
eISSN - 2050-6414
pISSN - 2050-6406
DOI - 10.1177/2050640619851683
Subject(s) - vedolizumab , medicine , infliximab , pharmacokinetics , monoclonal antibody , clinical trial , ulcerative colitis , inflammatory bowel disease , crohn's disease , biologic agents , pharmacology , intensive care medicine , disease , antibody , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom